Preparing for Growth – What’s Ahead for GCAC in 2025
As we step into Q1 2025, GCAC is transitioning into full-scale operations with a structured 2025 Battle Plan to drive growth. This update is the first in a series of communications aimed at keeping you informed about our strategy, partnerships, and execution path.
What’s New?
Since our last update, we have taken significant steps to strengthen our foundation and expand our market reach:
Technology & Platform Expansion:
Our blockchain-powered Efixii Uplift app continues to evolve, integrating coupon-based engagement strategies that connect brands, dispensaries, and consumers. At the same time, Citizen Green TV (CGTV)—our veteran-focused streaming platform—has expanded, enabling cannabis brands to advertise legally while integrating with Uplift NFT coupons for direct-to-consumer engagement.
Growing Market Presence:
We’ve solidified agreements with key industry players, including EMTRI and GCAC’s majority-owned Citizen Green Ventures (CGV), reinforcing our strategy to target veterans, uniformed services, and dispensaries.
Operational Readiness:
With established revenue contracts and a clear execution roadmap, GCAC is shifting from development to commercialization.
What’s Coming Next?
In the upcoming weeks, we will provide further details on:
How we have financed operations – Addressing how past funding mechanisms (private placements, debt settlements, and share issuances) have positioned us for this phase.
Our 2025 Battle Plan – A comprehensive overview of the strategies driving revenue generation and market penetration.
Ongoing Progress Reports – Regular updates through monthly Form 7 filings and material news releases to track execution.
2025 Battle Plan Overview
Our 2025 strategy focuses on three core revenue-driving initiatives:
√ Direct sales to veterans & uniformed services in Canada (via Health Canada-covered and out-of-pocket purchases).
√ EMTRI-driven cannabis sales in the USA (California, Nevada & Ohio).
√ Dispensary Upsell Program leveraging CGTV & Uplift technology to enhance consumer engagement.
Path to Revenue
While revenues will reveal themselves as we progress, we have solidified our understanding of pricing structures and have contracts to support these rates:
– Op Nobis (Canada) – CGV earns an average of $3.05/gram.
– EMTRI Gram Giveaway – GCAC earns USD$0.35/gram for blockchain fees.
– Dispensary Upsell Program – GCAC earns USD$6,131/dispensary/month based on rate card agreements.
This is only the beginning—as we execute our 2025 Battle Plan, we will continue to provide transparent updates on progress, challenges, and emerging opportunities.
Thank you for your continued support as we take this next step forward. Stay tuned for our next communication detailing financial strategy and execution planning.
